Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

NACompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Smoking CessationBiofeedback
Interventions
BEHAVIORAL

personalized cessation care

Individuals randomized to this condition will receive standard care (i.e., 5 counseling sessions and nicotine patch(NRT)) and 4 personalized videos with 5 packages of personalized print materials

BEHAVIORAL

bio feedback

Individuals randomized to this group will be provided with a personalized graph of their biomarker data from baseline, 6 and 8 weeks at the 8-week and 3-month study visits.

OTHER

standard care

Trial Locations (2)

29425

Medical University of South Carolina: Hollings Cancer Center, Charleston

06511

Yale University, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT02658032 - Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP) | Biotech Hunter | Biotech Hunter